Skip to main content

Advertisement

SpringerLink
Log in

Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates

  • Therapy in Practice
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Chronic pancreatitis is a clinical entity that results from the progressive inflammation and irreversible fibrosis of the pancreas resulting from the cumulative injury sustained by the pancreas over time. It is an illness with variable presentations that can severely impact quality of life, while its long-term complications such as exocrine pancreatic insufficiency (EPI), diabetes mellitus, and risk of pancreatic cancer can become life threatening. The diagnosis of chronic pancreatitis can be challenging as despite the recent advancements in imaging technology, the radiographic findings do not become prominent until late stages of disease. Thus, the physicians’ clinical acumen in obtaining thorough history taking focusing on risk factors, clinical symptoms, in addition to high-quality imaging, often guide to the accurate diagnosis of chronic pancreatitis. Endoscopy also plays a pivotal role in the diagnosis and management of chronic pancreatitis. Endoscopic ultrasound (EUS) is believed to be the most sensitive modality for diagnosing chronic pancreatitis. Despite efforts, however, natural history studies have demonstrated that 61% of individuals with chronic pancreatitis will require at least one endoscopic intervention, while 31% will require a surgical procedure as part of their management strategy. Recent advancements in genomic studies have furthered our understanding of the genetic polymorphisms that are associated with the pathogenesis of chronic pancreatitis. Genetic testing offers the potential to reveal treatable pancreatitis-related disorders, and can inform decision making with regard to radical therapies for persistent or severe disease such as total pancreatectomy with islet autotransplantation (TPIAT). The management of patients suffering from chronic pancreatitis often requires a multi-disciplinary approach, addressing pertinent symptoms as well as the sequelae of chronic inflammation and fibrosis. Abdominal pain is the prevailing symptom and most common complication of chronic pancreatitis, and impairs quality of life. Although heavily dependent on a wide range of analgesia, endoscopic treatment such as endoscopic retrograde cholangiopancreatography (ERCP) and surgical intervention can offer long-lasting relief of symptoms. For EPI, treatment with pancreatic enzyme supplements offers marginal-to-moderate relief. The most feared complication of chronic pancreatitis—the development of pancreatic cancer—has no known prevention measure to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med. 1995;332(22):1482–90.

    PubMed  CAS  Google Scholar 

  2. Whitcomb DC, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16(2):218–24.

    PubMed  PubMed Central  Google Scholar 

  3. Machicado JD, et al. Quality of life in chronic pancreatitis is determined by constant pain, disability/unemployment, current smoking, and associated co-morbidities. Am J Gastroenterol. 2017;112(4):633–42.

    PubMed  PubMed Central  Google Scholar 

  4. Amann ST, et al. Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas. 2013;42(2):293–300.

    PubMed  PubMed Central  Google Scholar 

  5. Schneider A, Lohr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42(2):101–19.

    PubMed  Google Scholar 

  6. Gardner, T.B., et al., ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol, 2020.

  7. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology. 1999;116(5):1132–40.

    PubMed  CAS  Google Scholar 

  8. Layer P, et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994;107(5):1481–7.

    PubMed  CAS  Google Scholar 

  9. Mergener K, Baillie J. Chronic pancreatitis. Lancet. 1997;350(9088):1379–85.

    PubMed  CAS  Google Scholar 

  10. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288(16):813–5.

    PubMed  CAS  Google Scholar 

  11. Toskes PP, et al. Vitamin B 12 malabsorption in chronic pancreatic insufficiency. N Engl J Med. 1971;284(12):627–32.

    PubMed  CAS  Google Scholar 

  12. Rickels MR, et al. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology. 2013;13(4):336–42.

    PubMed  CAS  Google Scholar 

  13. Sheth SG, et al. Academic Pancreas Centers of Excellence: guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology. 2017;17(3):419–30.

    PubMed  PubMed Central  Google Scholar 

  14. Kasper, D.L., Harrison’s gastroenterology and hepatology. Third edition. ed. 2017, New York: McGraw-Hill Education Medical. p.

  15. Bynigeri RR, et al. Pancreatic stellate cell: Pandora’s box for pancreatic disease biology. World J Gastroenterol. 2017;23(3):382–405.

    PubMed  PubMed Central  CAS  Google Scholar 

  16. Setiawan VW, et al. Uniting epidemiology and experimental disease models for alcohol-related pancreatic disease. Alcohol Res. 2017;38(2):173–82.

    PubMed  PubMed Central  Google Scholar 

  17. Kloppel G. Chronic pancreatitis, pseudotumors and other tumor-like lesions. Mod Pathol. 2007;20(Suppl 1):S113–31.

    PubMed  Google Scholar 

  18. Zhang L, et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas. 2011;40(8):1172–9.

    PubMed  CAS  Google Scholar 

  19. Conwell DL, et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43(8):1143–62.

    PubMed  PubMed Central  Google Scholar 

  20. Greer JB, Thrower E, Yadav D. Epidemiologic and mechanistic associations between smoking and pancreatitis. Curr Treat Options Gastroenterol. 2015;13(3):332–46.

    PubMed  PubMed Central  Google Scholar 

  21. Majumder S, Takahashi N, Chari ST. Autoimmune pancreatitis. Dig Dis Sci. 2017;62(7):1762–9.

    PubMed  CAS  Google Scholar 

  22. Whitcomb DC. Genetic risk factors for pancreatic disorders. Gastroenterology. 2013;144(6):1292–302.

    PubMed  PubMed Central  CAS  Google Scholar 

  23. Sankaran SJ, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology. 2015;149(6):1490–1500.e1.

    PubMed  Google Scholar 

  24. Yadav D, et al. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011;106(12):2192–9.

    PubMed  Google Scholar 

  25. Yadav D, Muddana V, O’Connell M. Hospitalizations for chronic pancreatitis in Allegheny County, Pennsylvania, USA. Pancreatology. 2011;11(6):546–52.

    PubMed  PubMed Central  Google Scholar 

  26. Levy P, et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United Eur Gastroenterol J. 2014;2(5):345–54.

    Google Scholar 

  27. Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):175–84.

    PubMed  PubMed Central  Google Scholar 

  28. Xiao AY, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45–55.

    PubMed  Google Scholar 

  29. Yadav D, et al. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: rationale and study design for PROCEED from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018;47(10):1229–38.

    PubMed  PubMed Central  Google Scholar 

  30. Tirkes T, et al. Quantitative MR evaluation of chronic pancreatitis: extracellular volume fraction and MR relaxometry. AJR Am J Roentgenol. 2018;210(3):533–42.

    PubMed  PubMed Central  Google Scholar 

  31. Hart PA, et al. Endoscopic pancreas fluid collection: methods and relevance for clinical care and translational science. Am J Gastroenterol. 2016;111(9):1258–66.

    PubMed  PubMed Central  CAS  Google Scholar 

  32. Ammann RW, et al. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology. 1984;86(5 Pt 1):820–8.

    PubMed  CAS  Google Scholar 

  33. Glass LM, et al. Spectrum of use and effectiveness of endoscopic and surgical therapies for chronic pancreatitis in the United States. Pancreas. 2014;43(4):539–43.

    PubMed  PubMed Central  Google Scholar 

  34. Krishna SG, et al. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas. 2017;46(4):482–8.

    PubMed  PubMed Central  Google Scholar 

  35. Bilal M, et al. Rising prevalence of opioid use disorder and predictors for opioid use disorder among hospitalized patients with chronic pancreatitis. Pancreas. 2019;48(10):1386–92.

    PubMed  Google Scholar 

  36. Shah R, et al. Incidence and predictors of 30-day readmissions in patients hospitalized with chronic pancreatitis: a nationwide analysis. Pancreatology. 2018;18(4):386–93.

    PubMed  Google Scholar 

  37. Hall TC, et al. The socio-economic impact of chronic pancreatitis: a systematic review. J Eval Clin Pract. 2014;20(3):203–7.

    PubMed  Google Scholar 

  38. Lohr JM, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153–99.

    PubMed  PubMed Central  Google Scholar 

  39. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120(3):682–707.

    PubMed  CAS  Google Scholar 

  40. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology. 1996;111(1):224–31.

    PubMed  CAS  Google Scholar 

  41. Cavallini G, et al. Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol. 1998;33(8):880–9.

    PubMed  CAS  Google Scholar 

  42. Frulloni L, et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis. 2009;41(4):311–7.

    PubMed  CAS  Google Scholar 

  43. Whitcomb DC, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology. 2008;8(4–5):520–31.

    PubMed  PubMed Central  Google Scholar 

  44. Nojgaard C, et al. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas. 2011;40(8):1195–200.

    PubMed  Google Scholar 

  45. Yadav D, et al. Pancreatitis: prevalence and risk factors among male veterans in a detoxification program. Pancreas. 2007;34(4):390–8.

    PubMed  Google Scholar 

  46. Deng X, et al. Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol. 2005;166(1):93–106.

    PubMed  PubMed Central  CAS  Google Scholar 

  47. Pandol SJ, et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology. 1999;117(3):706–16.

    PubMed  CAS  Google Scholar 

  48. Yadav D, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169(11):1035–45.

    PubMed  PubMed Central  Google Scholar 

  49. Morton C, Klatsky AL, Udaltsova N. Smoking, coffee, and pancreatitis. Am J Gastroenterol. 2004;99(4):731–8.

    PubMed  Google Scholar 

  50. Tolstrup JS, et al. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med. 2009;169(6):603–9.

    PubMed  Google Scholar 

  51. Aune, D., et al., Tobacco smoking and the risk of pancreatitis: A systematic review and meta-analysis of prospective studies. Pancreatology, 2019.

  52. Wittel UA, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol. 2006;101(1):148–59.

    PubMed  CAS  Google Scholar 

  53. Chowdhury P, et al. Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood). 2002;227(7):445–54.

    CAS  Google Scholar 

  54. Andriulli A, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010;39(8):1205–10.

    PubMed  Google Scholar 

  55. Talamini G, et al. Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications. Pancreas. 2007;35(4):320–6.

    PubMed  Google Scholar 

  56. Lankisch PG, et al. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol. 2009;104(11):2797–805 (quiz 2806).

    PubMed  Google Scholar 

  57. Muniraj T, et al. Increased awareness enhances physician recognition of the role of smoking in chronic pancreatitis. Pancreatology. 2019;19(4):500–6.

    PubMed  PubMed Central  Google Scholar 

  58. Phillips, A.E., et al., Known genetic susceptibility factors for chronic pancreatitis in patients of European ancestry are rare in patients of African ancestry. Pancreatology, 2018.

  59. Conwell DL, et al. Validation of demographics, etiology, and risk factors for chronic pancreatitis in the USA: a report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci. 2017;62(8):2133–40.

    PubMed  PubMed Central  Google Scholar 

  60. Masson E, et al. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008;123(1):83–91.

    PubMed  CAS  Google Scholar 

  61. Muddana V, et al. Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol. World J Gastroenterol. 2008;14(28):4486–91.

    PubMed  PubMed Central  CAS  Google Scholar 

  62. Pfutzer RH, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119(3):615–23.

    PubMed  CAS  Google Scholar 

  63. Santhosh S, et al. A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. Pancreas. 2008;36(3):317–20.

    PubMed  Google Scholar 

  64. Whitcomb DC, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14(2):141–5.

    PubMed  CAS  Google Scholar 

  65. Witt H, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38(6):668–73.

    PubMed  PubMed Central  CAS  Google Scholar 

  66. Hegyi E, et al. SPINK1 promoter variants in chronic pancreatitis. Pancreas. 2016;45(1):148–53.

    PubMed  CAS  Google Scholar 

  67. Campa D, et al. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Int J Cancer. 2018;142(2):290–6.

    PubMed  CAS  Google Scholar 

  68. Frulloni L, et al. Elevated serum levels of antibodies to carbonic anhydrase I and II in patients with chronic pancreatitis. Pancreas. 2000;20(4):382–8.

    PubMed  CAS  Google Scholar 

  69. Nahon Uzan K, et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol. 2005;3(9):903–9.

    PubMed  Google Scholar 

  70. Schneider A, et al. Prevalence and incidence of autoimmune pancreatitis in the population living in the Southwest of Germany. Digestion. 2017;96(4):187–98.

    PubMed  Google Scholar 

  71. Hirth M, et al. Monitoring and predicting disease activity in autoimmune pancreatitis with the M-ANNHEIM-AiP-Activity-Score. Pancreatology. 2018;18(1):29–38.

    PubMed  CAS  Google Scholar 

  72. Randall MM, et al. Pancreatitis in pre-adolescent children: a 10 year experience in the pediatric emergency department. BMC Emerg Med. 2019;19(1):71.

    PubMed  PubMed Central  Google Scholar 

  73. Shimosegawa T, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–8.

    PubMed  Google Scholar 

  74. Ferri V, et al. Diagnosis and treatment of pancreas divisum: a literature review. Hepatobiliary Pancreat Dis Int. 2019;18(4):332–6.

    PubMed  Google Scholar 

  75. Whitcomb DC. Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol. 2019;10(6):e00027.

    PubMed  PubMed Central  Google Scholar 

  76. Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. Jama. 2019;322(24):2422–34.

    PubMed  CAS  Google Scholar 

  77. Issa Y, et al. Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis. Eur Radiol. 2017;27(9):3820–44.

    PubMed  PubMed Central  CAS  Google Scholar 

  78. Tsao TF, et al. Color Doppler twinkling artifact related to chronic pancreatitis with parenchymal calcification. Acta Radiol. 2006;47(6):547–8.

    PubMed  CAS  Google Scholar 

  79. Alpern MB, et al. Chronic pancreatitis: ultrasonic features. Radiology. 1985;155(1):215–9.

    PubMed  CAS  Google Scholar 

  80. Remer EM, Baker ME. Imaging of chronic pancreatitis. Radiol Clin North Am. 2002;40(6):1229–42 (v).

    PubMed  Google Scholar 

  81. Kim DH, Pickhardt PJ. Radiologic assessment of acute and chronic pancreatitis. Surg Clin North Am. 2007;87(6):1341–58 (viii).

    PubMed  Google Scholar 

  82. Anderson SW, Soto JA. Pancreatic duct evaluation: accuracy of portal venous phase 64 MDCT. Abdom Imaging. 2009;34(1):55–63.

    PubMed  Google Scholar 

  83. Luetmer PH, Stephens DH, Ward EM. Chronic pancreatitis: reassessment with current CT. Radiology. 1989;171(2):353–7.

    PubMed  CAS  Google Scholar 

  84. Takehara Y, et al. Breath-hold MR cholangiopancreatography with a long-echo-train fast spin-echo sequence and a surface coil in chronic pancreatitis. Radiology. 1994;192(1):73–8.

    PubMed  CAS  Google Scholar 

  85. Hellerhoff KJ, et al. Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy. AJR Am J Roentgenol. 2002;179(1):121–9.

    PubMed  Google Scholar 

  86. Bali MA, et al. Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results. Eur Radiol. 2005;15(10):2110–21.

    PubMed  CAS  Google Scholar 

  87. Balci NC, et al. MRI and S-MRCP findings in patients with suspected chronic pancreatitis: correlation with endoscopic pancreatic function testing (ePFT). J Magn Reson Imaging. 2010;31(3):601–6.

    PubMed  Google Scholar 

  88. Balci C. MRI assessment of chronic pancreatitis. Diagn Interv Radiol. 2011;17(3):249–54.

    PubMed  Google Scholar 

  89. Lankisch PG. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia. Am J Gastroenterol. 2010;105(3):703–5.

    PubMed  Google Scholar 

  90. Akisik MF, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250(1):103–9.

    PubMed  Google Scholar 

  91. Iglesias-Garcia J, et al. Endoscopic ultrasound in the diagnosis of chronic pancreatitis. Rev Esp Enferm Dig. 2015;107(4):221–8.

    PubMed  Google Scholar 

  92. Kahl S, et al. EUS in the diagnosis of early chronic pancreatitis: a prospective follow-up study. Gastrointest Endosc. 2002;55(4):507–11.

    PubMed  Google Scholar 

  93. Aabakken L, et al. Minimal standard terminology for gastrointestinal endoscopy - MST 3.0. Endoscopy. 2009;41(8):727–8.

    PubMed  Google Scholar 

  94. Kalmin B, et al. Conventional versus Rosemont endoscopic ultrasound criteria for chronic pancreatitis: comparing interobserver reliability and intertest agreement. Can J Gastroenterol. 2011;25(5):261–4.

    PubMed  PubMed Central  Google Scholar 

  95. Wallace MB, et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest Endosc. 2001;53(3):294–9.

    PubMed  CAS  Google Scholar 

  96. Gardner TB, Gordon SR. Interobserver agreement for pancreatic endoscopic ultrasonography determined by same day back-to-back examinations. J Clin Gastroenterol. 2011;45(6):542–5.

    PubMed  Google Scholar 

  97. Albashir S, et al. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol. 2010;105(11):2498–503.

    PubMed  Google Scholar 

  98. Stevens T, et al. A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis. Gastrointest Endosc. 2008;67(3):458–66.

    PubMed  Google Scholar 

  99. Stevens T, et al. Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis. Dig Dis Sci. 2010;55(9):2681–7.

    PubMed  Google Scholar 

  100. Kuwahara T, et al. Usefulness of shear wave elastography as a quantitative diagnosis of chronic pancreatitis. J Gastroenterol Hepatol. 2018;33(3):756–61.

    PubMed  Google Scholar 

  101. Yamashita, Y., et al., Utility of elastography with endoscopic ultrasonography shear-wave measurement for diagnosing chronic pancreatitis. Gut Liver, 2019.

  102. Adler DG, et al. The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc. 2006;63(7):933–7.

    PubMed  Google Scholar 

  103. Axon AT, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25(10):1107–12.

    PubMed  PubMed Central  CAS  Google Scholar 

  104. Anand BS, et al. Effect of aging on the pancreatic ducts: a study based on endoscopic retrograde pancreatography. Gastrointest Endosc. 1989;35(3):210–3.

    PubMed  CAS  Google Scholar 

  105. Forsmark CE, Toskes PP. What does an abnormal pancreatogram mean? Gastrointest Endosc Clin N Am. 1995;5(1):105–23.

    PubMed  CAS  Google Scholar 

  106. Hoffmeister A, et al. English language version of the S3-consensus guidelines on chronic pancreatitis: definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol. 2015;53(12):1447–95.

    PubMed  CAS  Google Scholar 

  107. Shafiq, N., et al., Pancreatic enzymes for chronic pancreatitis. Cochrane Database Syst Rev, 2009(4):Cd006302.

  108. Parsi MA, et al. Findings on endoscopic retrograde cholangiopancreatography and pancreatic function test in suspected chronic pancreatitis and negative cross-sectional imaging. Clin Gastroenterol Hepatol. 2008;6(12):1432–6.

    PubMed  Google Scholar 

  109. Lankisch PG, et al. Steatorrhoea: you cannot trust your eyes when it comes to diagnosis. Lancet. 1996;347(9015):1620–1.

    PubMed  CAS  Google Scholar 

  110. Pezzilli R, Talamini G, Gullo L. Behaviour of serum pancreatic enzymes in chronic pancreatitis. Dig Liver Dis. 2000;32(3):233–7.

    PubMed  CAS  Google Scholar 

  111. Lohr JM, Oliver MR, Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United Eur Gastroenterol J. 2013;1(2):79–83.

    Google Scholar 

  112. Nousia-Arvanitakis S. Fecal elastase-1 concentration: an indirect test of exocrine pancreatic function and a marker of an enteropathy regardless of cause. J Pediatr Gastroenterol Nutr. 2003;36(3):314–5.

    PubMed  Google Scholar 

  113. Herzig KH, et al. Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus. BMC Geriatr. 2011;11:4.

    PubMed  PubMed Central  CAS  Google Scholar 

  114. Weintraub A, et al. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr. 2009;48(3):306–10.

    PubMed  Google Scholar 

  115. Amann ST, Josephson SA, Toskes PP. Acid steatocrit: a simple, rapid gravimetric method to determine steatorrhea. Am J Gastroenterol. 1997;92(12):2280–4.

    PubMed  CAS  Google Scholar 

  116. Calvo-Lerma J, et al. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption. Rev Esp Enferm Dig. 2017;109(10):684–9.

    PubMed  CAS  Google Scholar 

  117. Siegmund E, Lohr JM, Schuff-Werner P. The diagnostic validity of non-invasive pancreatic function tests–a meta-analysis. Z Gastroenterol. 2004;42(10):1117–28.

    PubMed  CAS  Google Scholar 

  118. Waxman I, Steer ML, Freedman SD. Endoscopically assisted direct pancreatic function testing: a simplified technique. Gastrointest Endosc. 1996;44(5):630.

    PubMed  CAS  Google Scholar 

  119. Go VL, Hofmann AF, Summerskill WH. Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology. 1970;58(3):321–8.

    PubMed  CAS  Google Scholar 

  120. Mullady DK, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Gut. 2011;60(1):77–84.

    PubMed  PubMed Central  Google Scholar 

  121. Drewes AM, et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017;17(5):720–31.

    PubMed  Google Scholar 

  122. Olesen SS, et al. Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment. Pain Rep. 2017;2(6):e625.

    PubMed  PubMed Central  Google Scholar 

  123. Wilcox CM, et al. Chronic pancreatitis pain pattern and severity are independent of abdominal imaging findings. Clin Gastroenterol Hepatol. 2015;13(3):552–60 (quiz e28-9).

    PubMed  Google Scholar 

  124. Olesen SS, et al. Pain severity reduces life quality in chronic pancreatitis: Implications for design of future outcome trials. Pancreatology. 2014;14(6):497–502.

    PubMed  Google Scholar 

  125. Bloechle C, et al. Quality of life in chronic pancreatitis–results after duodenum-preserving resection of the head of the pancreas. Pancreas. 1995;11(1):77–85.

    PubMed  CAS  Google Scholar 

  126. Pelli H, et al. Risk factors for recurrent acute alcohol-associated pancreatitis: a prospective analysis. Scand J Gastroenterol. 2008;43(5):614–21.

    PubMed  Google Scholar 

  127. Nikkola J, et al. Abstinence after first acute alcohol-associated pancreatitis protects against recurrent pancreatitis and minimizes the risk of pancreatic dysfunction. Alcohol Alcohol. 2013;48(4):483–6.

    PubMed  CAS  Google Scholar 

  128. Maisonneuve P, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut. 2005;54(4):510–4.

    PubMed  PubMed Central  CAS  Google Scholar 

  129. Barrett K, Chang YP. Behavioral interventions targeting chronic pain, depression, and substance use disorder in primary care. J Nurs Scholarsh. 2016;48(4):345–53.

    PubMed  Google Scholar 

  130. Thomas DA, et al. Role of alternative therapies for chronic pain syndromes. Curr Pain Headache Rep. 2016;20(5):29.

    PubMed  Google Scholar 

  131. Hart PA, Conwell DL. Chronic pancreatitis: managing a difficult disease. Am J Gastroenterol. 2020;115(1):49–55.

    PubMed  Google Scholar 

  132. Dumonceau JM, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—updated August 2018. Endoscopy. 2019;51(2):179–93.

    PubMed  Google Scholar 

  133. Guda NM, Partington S, Freeman ML. Extracorporeal shock wave lithotripsy in the management of chronic calcific pancreatitis: a meta-analysis. Jop. 2005;6(1):6–12.

    PubMed  Google Scholar 

  134. Rana MV, et al. Celiac plexus block in the management of chronic abdominal pain. Curr Pain Headache Rep. 2014;18(2):394.

    PubMed  Google Scholar 

  135. Kaufman M, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44(2):127–34.

    PubMed  Google Scholar 

  136. Owyang C, Louie DS, Tatum D. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest. 1986;77(6):2042–7.

    PubMed  PubMed Central  CAS  Google Scholar 

  137. Warshaw AL, Banks PA, Castillo CF-D. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology. 1998;115(3):765–76.

    PubMed  CAS  Google Scholar 

  138. Yaghoobi M, et al. Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis: meta-analysis and systematic review of randomized controlled trials. Can J Gastroenterol Hepatol. 2016;2016:8541839.

    PubMed  PubMed Central  Google Scholar 

  139. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Oxidative stress in blood of patients with alcohol-related pancreatitis. Pancreas. 2001;22(3):261–6.

    PubMed  CAS  Google Scholar 

  140. Van Gossum A, et al. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Dig Dis Sci. 1996;41(6):1225–31.

    PubMed  Google Scholar 

  141. Ahmed Ali, U., et al., Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst Rev, 2014(8): Cd008945.

  142. Talukdar R, Murthy HV, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2015;15(2):136–44.

    PubMed  CAS  Google Scholar 

  143. Rustagi T, Njei B. Antioxidant therapy for pain reduction in patients with chronic pancreatitis: a systematic review and meta-analysis. Pancreas. 2015;44(5):812–8.

    PubMed  CAS  Google Scholar 

  144. Talukdar R, et al. Ameliorating effect of antioxidants and pregabalin combination in pain recurrence after ductal clearance in chronic pancreatitis: Results of a randomized, double blind, placebo-controlled trial. J Gastroenterol Hepatol. 2016;31(9):1654–62.

    PubMed  CAS  Google Scholar 

  145. Singh, N., et al., Antioxidants for pancreatic functions in chronic pancreatitis: a double-blind randomized placebo-controlled pilot study. J Clin Gastroenterol, 2019.

  146. Ko KH, et al. Antioxidant therapy in chronic pancreatitis-promises and pitfalls. Ann Transl Med. 2019;7(Suppl 3):S115.

    PubMed  PubMed Central  Google Scholar 

  147. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. Jama. 1995;274(23):1870–3.

    PubMed  CAS  Google Scholar 

  148. Poulsen JL, et al. Pain and chronic pancreatitis: a complex interplay of multiple mechanisms. World J Gastroenterol. 2013;19(42):7282–91.

    PubMed  PubMed Central  Google Scholar 

  149. Olesen SS, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011;141(2):536–43.

    PubMed  CAS  Google Scholar 

  150. O’Brien T, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21(1):3–19.

    PubMed  Google Scholar 

  151. Drewes AM, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group. Scand J Pain. 2016;11:111–22.

    PubMed  Google Scholar 

  152. Drossman D, Szigethy E. The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl. 2014;2(1):22–30.

    PubMed  CAS  Google Scholar 

  153. Lankisch PG, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42(4):551–4.

    PubMed  PubMed Central  CAS  Google Scholar 

  154. Wooldridge JL, et al. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. J Cyst Fibros. 2009;8(6):405–17.

    PubMed  CAS  Google Scholar 

  155. D’Haese JG, et al. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. Pancreas. 2014;43(6):834–41.

    PubMed  Google Scholar 

  156. Gan KH, et al. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values. Aliment Pharmacol Ther. 1996;10(5):771–5.

    PubMed  CAS  Google Scholar 

  157. Bruno MJ, et al. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. Dig Dis Sci. 1998;43(1):203–13.

    PubMed  CAS  Google Scholar 

  158. de la Iglesia-García D, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017;66(8):1354–5.

    PubMed  Google Scholar 

  159. Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62(7):1745–50.

    PubMed  PubMed Central  Google Scholar 

  160. Bellin MD, et al. Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States. Am J Gastroenterol. 2017;112(9):1457–65.

    PubMed  PubMed Central  Google Scholar 

  161. Woodmansey C, et al. Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care. 2017;40(11):1486–93.

    PubMed  Google Scholar 

  162. Hart PA, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016;1(3):226–37.

    PubMed  PubMed Central  Google Scholar 

  163. Lowenfels AB, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328(20):1433–7.

    PubMed  CAS  Google Scholar 

  164. Raimondi S, et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol. 2010;24(3):349–58.

    PubMed  Google Scholar 

  165. Canto MI, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339–47.

    PubMed  Google Scholar 

  166. Canto MI, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006;4(6):766–81 (quiz 665).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Digestive Disease Institute, 9500 Euclid Avenue/A31, Cleveland, OH, 44195, USA

    Adam Kichler & Sunguk Jang

Authors
  1. Adam Kichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunguk Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunguk Jang.

Ethics declarations

Funding

No funding was recieved for the preparation of this manuscript.

Conflict of interest

Adam Kichler has no conflict of interest to disclose. Sunguk Jang is a consultant for Boston Scientific as a key opinion leader.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kichler, A., Jang, S. Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates. Drugs 80, 1155–1168 (2020). https://doi.org/10.1007/s40265-020-01360-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-020-01360-6

Search

Navigation